Molecular identification of Trichomonas vaginalis compared to culture among women in child - bearing age in West Bank - Palestine by Houso, Yasmeen Ahmad
 1 
 
 
 
 
 
 
 
 
 
 
 
Bir Zeit University 
 
 
 
 
 
Molecular identification of Trichomonas vaginalis 
compared to culture among women in child-
bearing age in West Bank-Palestine 
 
 
 
By: 
 
Yasmeen Ahmad Houso 
 
 
Advisors: 
 
                                   Dr.Tamer Essawi 
                                   Dr.Mohammad Farraj 



2006 
 2 
 
 
 
 
 
 
 
 
 
 
CHAPTER ONE 
 
 
 
 
 
 
 
 
 
 
 
 3 
1.   INTRODUCTION 
 
Trichomonas vaginalis, a flagellated parasitic protozoan typically 
pyriform in culture and amoeboid when adhering to mammalian cells 
(1); it is the etiologic agent of trichomoniasis, a sexually transmitted 
disease (STD) of worldwide importance. Trichomoniasis is the most 
common nonviral STDs, usually surviving only in human urogenital 
tract and it is associated with many perinatal complications and an 
increased incidence of HIV transmission (2). 
Recent data have shown that the annual incidence of 
trichomoniasis is more than 180 million cases worldwide (3,4,5), 
World Health Organization (WHO) estimates that T.vaginalis 
accounts for approximately half of all curable sexually transmitted 
diseases worldwide (2). 
This disease has important medical, social, and economical 
implications (6). Women who are infected during pregnancy are 
predisposed to premature rupture of the placental membranes, 
premature labor, and low-birth-weight infants. Also linked to this 
disease are cervical cancer, atypical pelvic inflammatory disease, and 
infertility (2, 7, 8).  
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T. vaginalis was first described by Donné in 1836. Until the 1950s, 
this organism was recognized as commensal (9). Subsequently, its 
role in causing the sexually transmitted disease (trichomoniasis) was 
recognized. Research on this organism has been in a progression of 
phases throughout the last 60 years (2). During the 1960s and 1970s, 
research had focused on biochemical tests and microscopic 
examination to understand the growth characteristics and behavior of 
the organism. It was not until the 1980s that immunologic methods 
and molecular biological techniques became available and were 
applied to study the pathogenesis and immunology of this organism 
(2). 
1.1 Morphology and life cycle 
Trichomonas vaginalis is a microscopic, motile, anaerobic and 
flagellated protozoan parasite found in women’s vagina and men’s 
urethra. T. vaginalis contains five flagella, four of which are located 
at its anterior portion; the fifth flagellum is incorporated within the 
undulating membrane. 
T. vaginalis possesses no mitochondria, instead producing some of 
its ATP in hydrogen-producing organelles called hydrogenosomes. It 
has a nucleus, an axostyle, a glycogen-rich cytoplasm, a variety of 
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vacuoles (including lysosomes), and numerous micro-tubules with 
varied structures (2,10,11). The axostyle is a distinctive feature of T. 
vaginalis that runs the length of the organism and appears to protrude 
from the posterior end. It is a cytoskeletal element composed of 
concentric rows of microtubules and is believed to function in the 
attachment of the parasite to epithelial cells. 
 The life cycle of T. vaginalis is simple in that the trophozoite is 
transmitted through coitus and no cyst form is known. The 
trophozoite divides by binary fission and, in natural infections, gives 
rise to a population in the lumen and on the mucosal surfaces of the 
urogenital tracts of humans (2, 10).The incubation period typically 
ranges from 3-28 days (12). 
1.2 Clinical manifestation  
Trichomoniasis can be symptomatic or asymptomatic in both 
sexes. Men are most frequently considered to be asymptomatic 
carriers of T.vaginalis, representing an important vector and reservoir 
(13). Demonstration of this organism in men has always been 
difficult.  
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Trichomoniasis has been associated with vaginitis, cervicitis, 
urethritis, and adverse birth outcomes (6, 14, 12). Infection with T. 
vaginalis could have an important role in transmission and acquisition 
of HIV (9, 12, 15). Other complications associated with 
trichomoniasis include increased risks for the following: infertility, 
development of atypical pelvic inflammatory disease, infection 
following gynecologic surgery, and cervical inflammatory neoplasia. 
There have also been high rates of correlation between trichomoniasis 
and pregnancy complications in women. In men, T. vaginalis has 
been linked to male factor infertility and as a common cause of non-
gonococcal urethritis (NGU) (7, 8, 16). 
The primary symptom of trichomoniasis in women is a copious, 
foul-smelling vaginal discharge that is often accompanied by burning 
or itching but approximately half of all women will be asymptomatic 
(6), and thus screening for disease is important.  
This discharge is most often gray, but can be yellow or green and 
is occasionally frothy or blood tinged. Many women may also 
experience painful or difficult coitus. Urethral involvement occurs in 
a large number of cases and is characterized by dysuria (painful 
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urination) and frequent urination. The absence of discharge therefore 
does not rule out the infection, nor should the presence of discharge 
be taken as the sole criteria for diagnosing T.vaginalis (2). Various 
sociodemographic factors have been correlated with presence of 
T.vaginalis, and may be used to predict infection. It is rarely reported 
in females before puberty and after menopause, but is common during 
the child-bearing years and peaks during pregnancy (6). 
1.3 Pathophysiology 
The normal physiologic vaginal discharge comprises vaginal 
secretions, exfoliated cells and cervical mucus. The frequency of 
vaginal discharge varies with age, menstrual cycle, pregnancy and use 
of oral contraceptives. The normal vaginal environment is 
characterized by a dynamic interrelationship between Lactobacillus 
acidophilus and other endogenous flora, estrogen, glycogen, vaginal 
pH and metabolic by-products of flora and pathogens. L. acidophilus 
produces hydrogen peroxide, which is toxic to pathogens and keeps 
the healthy vaginal pH between 3.8 and 4.2.  Vaginitis occurs because 
the vaginal flora has been altered by the introduction of Trichomonas 
vaginalis or changes in the vaginal environment that allow pathogens 
to proliferate (17). 
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Antibiotics, contraceptives, sexual intercourse, douching, stress 
and hormones, deodorants soaps, vaginal sprays, tampons or pads, 
colored or perfumed toilet tissue, bubble bath, laundry detergents 
(especially those with enzymes), fabric softeners, frequent minipad 
use, tight-fitting synthetic underwear, swimming pools or hot tubs, 
and vaginal contraceptives or condoms (3) can change the vaginal 
environment and allow pathogens to grow (3,17). 
In trichimoniasis, it is believed that some inciting event decreases 
the number of hydrogen peroxide producing L. acidophilus organisms 
(17). The resultant change in pH allows proliferation of organisms 
that are normally suppressed. These organisms produce metabolic 
byproducts,such as amines, that further increase the vaginal pH and 
cause exfoliation of vaginal epithelial cells. In patients with 
trichomoniasis, changes in estrogen and progesterone levels, as well 
as elevations of vaginal pH and glycogen levels, may enhance the 
growth and virulence of T. vaginalis (18). 
The vagina infected with T. vaginalis becomes less acidic and 
frequently reaches a pH level greater than 5.  This favors the 
overgrowth of bacteria, resulting in increased colonization of the 
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lower genital tract by anaerobes.  This may increase the risk of 
postoperative infection in the patient who is preparing to undergo 
pelvic surgery (17). 
1.4 Pathogenesis and virulence 
Pathogenesis and virulence of trichomoniasis is not fully 
understood.  Adhesion of T. vaginalis to vaginal epithelial is believed 
to be the primary factor contributing to the pathogenesis of the 
organism. Although several adhesion molecules have been identified 
on the surface of this parasite, little is known about host cell 
receptors. There is evidence suggesting that T. vaginalis actually 
binds to the extracellular matrix glycoproteins, laminin and 
fibronectin (19).  It was suggested by many reports that the 
association of T. vaginalis with these two plasma proteins contributes 
to host parasitism (20).  
 Application of antibodies to block binding of adhesion molecules 
to targets on vaginal epithelial cells reduced drastically the adhesion 
of the parasite to the cells. In addition there was no sign of any 
cytopathic effects on these cells in vitro (21). Contact of T. vaginalis 
to vaginal epithelium caused morphological changes in the parasite 
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where it became flattened with concomitant up-regulation in the 
expression of many genes including those encoding for the adhesion 
molecules (22).  
Cysteine proteinases have been known to play an important role in 
the virulence of all parasites in general and T. vaginalis in particular. 
Many functions have been attributed to these molecules including 
adherence and cytotoxicity.  
Incubation of live T. vaginalis with human vaginal epithelial cell 
monolayers produced disruption of host cells within two hours and 
resulted in total loss of cell viability after extended exposure to the 
parasite (23). Expression of proteolytic activity and localization of 
adhesion molecules on the surface of the parasite is controlled by the 
presence of iron. Likewise, the transcription of Ap65-1, an adhesion 
protein, is regulated by the presence of iron-responsive DNA 
elements (24). 
The cytopathic effect of T. vaginalis on host cells is considered to 
be significant in the pathogenesis of this parasite. T. vaginalis is 
considered as an extracellular parasite that induces cytopathic effect 
on host cells via two major mechanisms, one is contact-dependent 
and the other is contact independent. Contact dependent cytopathic 
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effect is mediated by several cysteine proteinases and hemolytic 
factors as mentioned previously. It was found that T. vaginalis 
elaborates soluble factors or toxins that have the ability to damage 
target cells in vitro (25). One toxin or soluble factor was referred to as 
the lytic factor (LF). LF was isolated, purified and its molecular 
characteristics were determined. Additional testing on the activity of 
the lytic factor revealed that it is a phospholipase. LF has the ability 
to hydrolyze phosphotidylcholine yielding products similar to those 
produced by phospholipase A2 (PLA2).  This indicates that the major 
enzymatic component of LF that mediates host cell lysis is PLA2. LF 
is considered to be an important virulence factor of T. vaginalis which 
mediates host cell lysis, tissue damage and inflammation in 
trichomoniasis (25). 
1.5 Epidemiology  
It is estimated that one in five sexually active women will be 
infected with T.vaginalis in their lifetime. Transmission is mainly by 
physical contact as T.vaginalis can only survive outside the host for a 
short period of time (26). 
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In the United States annually, an estimated 8 million women are 
infected with T.vaginalis, and the annual number worldwide is 
approximately 180 million (3, 4,5).  
Trichomonal infection has been encountered in every continent 
and climate and with no seasonal variability. It has a cosmopolitan 
distribution and has been identified in all racial groups and 
socioeconomic strata. Although trichomoniasis is the most common 
of STIs, data on prevalence and incidence are limited (27).  
In pregnancy, the reported prevalence rate of trichomoniasis 
ranges from 9% to 47% (28).  Several clinical studies reported high 
incidence rates of trichomoniasis among pregnant women. The 
prevalence of trichomoniasis amongst pregnant women in Africa 
show rates ranging from 9.9% in Central African Republic to 41.4% 
in South Africa (27).  
Studies on the prevalence of trichomoniasis in the Mediterranean 
region have been obtained on women attending family planning, 
reproductive and gynecological clinics. In Izmir (Turkey), the 
prevalence of trichomoniasis was found to be 15.4% (29). The 
prevalence of trichomoniasis among Iraqi women was found to be 
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11.3%; another study conducted in Basra (Iraq) revealed a prevalence 
rate of 13% (30). Prevalence was found to be (8.7%) among married 
women in Upper Egypt (31), while the prevalence in Israel was found 
to be 8.1% (32). 
Humans are the only natural host for T. vaginalis. The trophozoite 
is transmitted from one person to another, usually by sexual 
intercourse which includes vaginal, oral or anal sex and from a 
mother to child during birth (2,10). Rarely, T. vaginalis is transmitted 
by sharing towels, flannels, hot baths or jacuzzis.  Newborn infants of 
mothers infected by T. vaginalis have on occasion acquired a 
T. vaginalis urinary tract or vaginal infection. The organisms were 
acquired by 2 to 17% of female neonates of infected women (33). In 
addition, neonates have been infected during the birth process. 
Newborn girls can acquire the infection from their infected mothers 
during passage through the birth canal. In such cases, the infection 
tends to remain asymptomatic until puberty (11, 34, 35). 
Finally, trichomoniasis facilitates the spread of HIV epidemic. 
Theoretically, calculations concluded that infection with T. vaginalis 
increased the risk of HIV transmission by 90%. In a population with 
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25% prevalence of trichomoniasis, approximately 20% of cases of 
HIV would be attributable to trichomoniasis. Rates of trichomoniasis 
and HIV seem to be directly proportional (36). 
1.6 Treatment 
 The standard treatment for trichomoniasis is 250 mg of 
metronidazole, given orally, three times a day for 7 days, or in a 
single 2g-dose. Both the infected patient and sexual partner, whether 
symptomatic or asymptomatic, should be treated to prevent 
reinfection (27,37). The single 2-g dose of metronidazole is the 
treatment currently recommended by the Centers for Disease Control 
and Prevention for women at any stage of pregnancy, also for 
lactating mothers followed by a 24-h interruption in breast feeding to 
prevent neonatal exposure to drug (37).  
As regarding prevention and treatment, both partners should 
receive careful examination and treatment. Furthermore, medical 
examination instruments must be sterile in order to prevent 
transmission of the disease. Routinely screening and treating women 
for Trichomonas vaginalis before any reproductive tract surgery and 
also before pregnancy and after delivery or abortion may help to 
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prevent the occurrence of infection. Barrier protection (condoms) 
should be used during intercourse until the infection is eradicated in 
both partners. The population must be educated about this disease and 
the means of transmission, since education on sexual behaviour and 
genital hygiene may help in its prevention and control (37). 
 
1.7 Diagnosis 
In areas where diagnostic methods are limited, management of 
trichomoniasis is usually as part of a clinical syndrome for women 
characteristics of the vaginal discharge, including color and odor, 
which are poor predictors of T. vaginalis (29, 31). Since no symptom 
alone or in combination is sufficient to diagnose T. vaginalis infection 
reliably, laboratory diagnosis is necessary (36).  
Traditionally, diagnosis of trichomoniasis in women has relied on 
microscopic examination of wet mount preparations made directly 
from vaginal secretions. Although rapid and inexpensive, this 
technique is relatively insensitive, has a low sensitivity of 36-75% 
(5,38, 39, 40). When motility is lost, it is difficult to distinguish T. 
vaginalis  from white blood cells and there is usually an increased 
number of polymorphonuclear white blood cells with T. vaginalis 
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infection (41). Studies have reported a range of false negatives on wet 
mounts from 23% to 58% (41). Therefore, it is necessary to examine 
fresh specimens as quickly as possible after collection. Culture of 
trichomonads from vaginal swab specimens and urine (16) remains 
the "gold standard" against which the performance of other diagnostic 
methods is measured. Unfortunately, culture is time-consuming, with 
results usually being available only 48 to 72 h after inoculation of the 
culture medium. Also, it is impractical in many settings since 
specialized laboratory equipment such as incubators and microscopes 
is required.  
Recently, a number of PCR assays (42,43) have been developed 
for the detection of T. vaginalis and these assays have generally 
proved more sensitive than culture; however, PCR also requires a 
dedicated laboratory, sophisticated equipment, and specially trained 
laboratorians. 
Guillermo et al. (44) developed a PCR method using primers that 
produced a segment of B-tubulin sequence with 97% sensitivity and 
98% specificity. Their primers did not amplify genes of other species 
of trichomonas, intestinal flagellates and bacterial agents of vaginitis. 
Patel found that the sensitivity of the polymerase chain reaction 
 17 
technique was 95% and the specificity was 98% compared to other 
diagnostic tests (45).  
Based on different studies, PCR is very sensitive and specific for 
detection of Trichomonas vaginalis suggesting this method as the 
gold standard instead of other screening methods (44, 46). 
1.8 Statement of the problem 
Trichomoniasis is the most common sexually transmitted diseases 
(STDs) worldwide. It is caused by the parasite Trichomonas vaginalis 
(TV). An estimated 180 million new infections occur annually 
(3,4,5). In the United States the incidence was found to be 8 million 
new cases annually (5).  
According to the Palestinian Ministry of Health, reporting of 
sexually transmitted disease is categorized according to etiological 
causes and syndromic diagnosis. The number of cases for patients 
with trichomoniasis in Palestine was estimated to be 103 cases in 
females and 36 cases in males per 100,000 (47).  
Clinical studies have demonstrated that trichomoniasis may have 
serious side effects both in pregnancy and in a predisposition to 
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retrovirus infection (27). T. vaginalis causes a common genitourinary 
infection, which is frequently asymptomatic; it has been estimated 
that 10-50% of T.vaginalis infections in women are asymptomatic 
(11, 19, 47, 48). Infestation with TV is a common and potentially 
morbid infection. In addition to reproductive tract discharge and 
irritation, infection with these protozoa is increasingly to be 
associated with reproductive tract complications, including post 
abortion infection, post cesarean infection, preterm birth (38,39) and 
low birth weight infants. T. vaginalis infection has been suggested 
also as a risk factor for developing cervical cancer. Other 
complications of T. vaginalis include pelvic inflammatory disease, 
tubal infertility, vaginitis and urethritis (19,38,39). 
 T. vaginalis is a common pathogen that is associated with diverse 
pregnancy outcomes and may serve as a cofactor in human 
immunodeficiency virus (HIV) transmission (36,38,39). 
In this study, a PCR targeting the beta-tubulin genes of 
T. vaginalis was used for the detection of the organism in vaginal 
swab samples. The targeted genes encode the amino acid sequence of 
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beta-tubulin protein, a major component of the T. vaginalis 
cytoskeleton. 
1.9 Specific Aims:  
The specific aims of this study were: 
1. To determine the infection rate of T.vaginalis among women in 
childbearing age in the West Bank - Palestine. 
2. To establish baseline data on the infection rate of trichomoniasis 
that could help the policy makers in Ministry of Health to take 
decisions for control and prevention of the infection according to 
data obtained.  
3. Determine the distribution of trichomoniasis in the West Bank. 
4. Determine the age distribution of the disease according to age. 
5. To evaluate current culture methods using Trichomonas medium 
No. 2, for the purpose of improving detection methods for T. 
vaginlis. 
6. To adopt molecular amplification methods (PCR) using specific 
primers (BTUB 9/2) to identify T. vaginalis infections. 
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2.   MATERIALS AND METHODS 
      2.1 Vaginal swabs: 
     A total of 1207 women in childbearing age attending the 
governmental, UNRWA and private sector reproductive health clinics 
in the West Bank-Palestine, between October 2004 and June 2006 
were screened for trichomoniasis which is considered one of the most 
commonly sexually transmitted diseases. Samples were collected by 
physician of the clinic after getting the women's written consent on a 
special form prepared for the purpose of this research; vaginal pH 
level was determined by placing litmus paper against the lateral 
vaginal wall.  
The number of samples was selected accordancing to the 
estimated population in the year 2003 (see annex 1). Samples were 
collected randomly from women in all districts in the West Bank-
Palestine. Vaginal swabs were collected and sent immediately to the 
Central Public Health Laboratory in Ramalla. Within 6-8 hours of 
sample collection, samples were cultured in the broth medium 
Trichomonas medium No. 2, then incubated at 37°C for up to 5 days. 
Microscopic wet mount examination of the broth was performed daily 
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for five days. All positive cultures were stored at – 70°C for further 
molecular analysis.  
The questionnaire was designed according to WHO 
recommendations for sexually transmitted infections and HIV ( see 
annex 2, 3).      
2.2 Examination of Trichomonas vaginalis by Culture:  
Swabs sent to the laboratory from the collection clinics were 
immediately used to inoculate the medium by cutting the swabs and 
putting it in the culture medium, and then cultures were incubated at 
37°C for 24-hrs to check up the motility of Trichomonas vaginalis 
microscopically. Positive cultures stored at -70°C for PCR. Were if 
the sample was negative, it was reincubated and checked daily for 5 
days. 
Trichomonas medium No.2 (Oxoid) was selected for the isolation 
of Trichomonas vaginalis. This medium contains liver digest, iron, 
glucose , chloramphenicol, tryptone soy broth CM129, horse serum 
SR35 for enrichment , calcium pantothenate (water soluble) and 
distilled water. 
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2.3 DNA Extraction: 
DNA samples were prepared by a rapid boiling method (8, 13). A 
100 µl of T. vaginalis cultures were mixed with 400 µl of sterile 
water, 15µl of lysis solution (64 % Guanidine thiocyanate, Tris-HCL 
buffer, 3% Dithiothreitol, <1% glycogen) and were boiled at 100°C 
for 10 min. Then, these preparations were then centrifuged at 
14,000 × g for 15 min. 
2.4 PCR: 
PCR has been used for amplification of a fragment of the beta-
tubulin gene of T. vaginali. This was developed for the detection of 
the organism in vaginal swab samples utilizing the BTUB 9/2 primer 
set. The beta-tubulin genes encode beta-tubulin protein, a major 
component of the T. vaginalis cytoskeleton. 
2.4.1 PCR primers:  
The primers (BTUB 9/2) used in this study were designed to target 
a conserved region of the beta-tubulin genes of T. vaginalis. To 
improve the specificity, primer sequences were selected from the 
regions of the T. vaginalis beta-tubulin genes that differed 
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substantially from the beta-tubulin gene sequences of humans and 
other microorganisms. The primer set used in this study was:  
BTUB 9, 5 CAT TGA TAA CGA AGC TCT TTA CGA T 3 (9/25) 
BTUB 2, 5 GCA TGT TGT GCC GGA CAT AAC CAT 3  (2/24) 
2.4.2 PCR procedure 
PCR was performed in a total volume of 50-100 µl for each 
specimen. The PCR mixture contained: 0.25 µM of each primer, 0.1 
mM deoxynucleoside triphosphates, 1X PCR buffer (10 mM Tris HCl 
[pH 8.4], 50 mM KCl), and 0.5 mM MgCl2 , 0.5 U of Taq polymerase 
(PeqLab-Germany); 10 µL template DNA were added to respective 
tubes .  
DNA amplification was performed in a thermocycler 
(BioMed,Theres,Germany Theres). The PCR consisted of 40 cycles 
each consisting of denaturation at 94°C for 30s, annealing at 63°C for 
30s, and extension at 72°C for 1 min. A precycling denaturation at 
94°C for 5 min and a final extension at 72°C for 7 min were also 
applied for each PCR run. Ten microliters (10µl) of PCR products 
 25 
were electrophoresis on a 2 % agarose gel containing ethidium 
bromide (0.5 mg/ml).  
Positive and negative controls were included in all PCR runs. 
DNA extract from a clinical isolate Trichomonas vaginalis grown in 
Trichomonas medium No.2 was used as a positive control. 
2.5 Gel Electrophoresis 
The electrophoresis was performed in 1× TBE at a constant 
current of 80 V for 2-hrs. The gels were viewed and photographed 
under UV transillumination. The sizes of the amplified products were 
assessed by comparison with a commercial 100-bp molecular weight 
ladder (PeqLab-Germany). 
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3.   Results 
A total of 1207 women attending the reproductive health clinics 
were screened for T.vaginalis infection. A positive result was defined 
as the presence of motile trichomonads upon the microscopic 
examination of a wet mount preparation from culture enrichment of 
T.vaginalis from vaginal swabs. 
Of the 1207 women specimens cultured on broth containing 
trichomonas medium No. 2, 164 cultures (13.6 %) were found to be 
positive for T. vaginalis (Table 1). Several variables were taken into 
consideration during this study. These variables including residency 
distribution (Table 2) , age (Table 3), marital status, pregnancy and 
lactation (Table 4), women using contraceptives (Table 5), 
socioeconomic conditions, education (Table 6) and manifestation of 
clinical symptoms (Table 7 ).  
For a total of 1207 women examined in the West Bank, 164    
(13.6 %) women were found to be infected with T. vaginalis. The 
high infection rate was observed in Hebron and Salfit. 
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Table 1: Distribution of infection rate of T. vaginalis by districts. 
 
There was no significant difference of infection by residential area 
despite that infection was more common among women living in 
refugee camps (18.6%) as shown in Table (2). 
Table 2: Infection rate of T. vaginalis according to residency 
distribution. 
West Bank No. examined No. positive (culture) 
  No. % 
Jerusalem 60 10 16.7 
Jericho 55 7 12.7 
Bethlehem 110 11 10 
Hebron 301 57 18.9 
Tulkarem 101 11 10.9 
Nablus 185 29 15.7 
Qalqilia 53 7 13.2  
Jenin 174 16 9.2  
Salfit 35 7 20  
Ramallah 133 9 6.8  
Total 1207 164 13.6  
District No. examined No. positive (culture) 
  No. % 
Urban 483 69 14.3  
Rural 665 84 12.6  
Camps 59 11 18.6  
Total  1207 164 13.6 
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The highest infection rate (20.7 %) of T. vaginalis was observed 
among women 18 years old and younger (Table 3). In contrast the 
lowest infection rate (6.3 %) was observed among women whose age 
were 46 years and older as shown in Table 3. 
Married women showed an infection rate of 13.6 % and widows 
showed an infection rate of (14.3%). However, the total number of 
widows who participated in this study was only 7, which did not 
allow a reliable statistical evaluation of the infection rate in this 
group. Additionally, there were 3 divorced women in the study all of 
which were negative for trichomoniasis. 
Table 3: Infection rate of T. vaginalis according to age 
Age group Number/group Positive cases (culture) 
  No. % 
(years)    
15-18 29 6 20.7 
19-25 268 42 15.7 
26-30 262 36 13.7 
31-35 264 32 12 
36-45 314 44 14 
Over 46 64 4 6.3 
Total  1207 164 13.6 
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Considering the infection rate in pregnant and lactating women, it 
was found that pregnant women showed a higher and statistically 
significant infection rate (28.1 %) as compared to lactating women 
(11.4 %) as well as women not belonging to these two groups (10.9 
%) - neither pregnant nor lactating- (Table 4). However, no 
statistically significant difference in the infection rate was observed 
between lactating women and other women not belonging to pregnant 
or lactating groups (Table 4). 
Table 4: Infection rate of T. vaginalis according to status of    women. 
Status  n 
Positive 
cases 
(culture) 
  No. % 
Pregnant 178 50 28.1 
lactating 324 37 11.4 
others 705 77 10.9 
Total  1207 164 13.6 
* Others: women who were neither pregnant nor lactating 
T. vaginalis infection was more common among women who did 
not use contraceptives (17.1 %) than among those using oral 
contraceptive (9.2 %), IUD (11.6 %), (Table 5), condoms (11.1 %) 
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and to a lesser extent among women using injections (14.3 %) (Table 
5). 
Table 5: Infection rate of T. vaginalis according to contraceptive        
methods. 
Contraceptives n 
Positive 
cases 
(culture) 
  No. % 
IUD 458 53 11.6 
Pills 130 12 9.2 
injection 7 1 14.3 
Condom  81 7 11.1 
Not-Use 594 91 17.1 
Total  1207 164 13.6 
* %: number of positive cases per group / number of women       
per group 
On the other hand, the infection rate of T. vaginalis among 
housewives (13.7%) was higher than working women (11.7%), and 
among women with elementary education (13.8%) was higher than 
among women with higher education (11.4%) (Table 6). 
Additionally, a comparison of the infection rate among various 
socioeconomic classes, low, moderate and high income showed an 
infection rate of 14.4 %, 12.8 %, 15.8% respectively. However there 
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was no statistical difference observed in the infection rate among the 
different women’s groups (mentioned previously and shown in Table 
6).   
Table 6: Infection rate of T. vaginalis according to occupation, 
education and economic status. 
 
 
 
 
 
 
  
Furthermore, Table 7 shows the relationship between the clinical 
symptoms manifested by the affected women seeking medical help 
due to vaginitis and the number of cases attributed to T. vaginalis as 
confirmed by the culture method. 
 
Positive 
cases(culture) 
Variable n No. % 
Occupation    
Working outside 77 9 11.7 
Housewife 1130 155 13.7 
Educational 
level    
Low 1084 150 13.8 
High 123 14 11.4 
Economic status    
Low 542 78 14.4 
Moderate 646 83 12.8 
High 19 3 15.8 
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Table 7: Infection rate of T.vaginalis according to clinical features 
 Positive cases 
Presenting 
symptoms n No. % 
Vaginal discharge 990 130 13.1 
Soreness 382 57 14.9 
Urinary symptoms 489 67 13.7 
Pelvic pain 302 48 15.9 
irritation 458 68 14.8 
pH > 4 1125 154 13.7 
 
The percentage of cases presented with increased vaginal pH and 
vaginal discharge was 79.2 % and 93.9 %, respectively, relative to 
culture-confirmed infection and 13.7% and 13.1% relative to total 
study sample respectively.  
In this study, 100 specimens were randomly selected from a total 
of 164 specimens that were positive by the culture method and 
analysed for presence of T.vaginalis by PCR. The DNA was extracted 
and purified from these 100 specimens and subjected for PCR 
amplification followed by analysis of PCR amplicons by agarose gel 
electrophoresis. The primer set BTUB 9/2 used for PCR amplification 
amplified the predicted 112-bp product in 82 of the selected 100 
 34 
specimens. A representative agarose gel electrophoresis for PCR 
products using primer pair BTUB 9/2 shows the successful 
amplification of the 112-bp fragment from the BTUB gene of 
T.vaginalis (Fig 1).   The sensitivity of PCR to identify T. vaginalis as 
compared to culture was 82%.  
 
 
 
 
 
Figure 1. A representative agarose gel electrophoresis for PCR products 
Lane 2:100 bp DNA Ladder, lanes 3-13: culture sample positive for 
T.vaginalis, lane 14: negative control, lane 15: ladder. 
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4.   DISCUSSION 
Trichomoniasis is the most common nonviral sexually transmitted 
disease (STD) worldwide.  T.vaginalis is the third most common 
cause of vaginitis. World Health Organization (WHO) estimates that 
T. vaginalis accounts for approximately half of all curable sexually 
transmitted diseases worldwide (6). Annually it affects 180 million 
women worldwide (3, 4). 
The aim of this study was to evaluate and compare new techniques 
used for accurate identification of T. vaginalis. Traditional methods 
for the identification of T. vaginalis rely on microscopic examination 
(wet mount). Although rapid and inexpensive, this technique has a 
low sensitivity of 36-75 %. In addition, high numbers of the parasite 
with the characteristic jerky motility must be present for accurate 
diagnosis to be made. This requires experienced and trained 
laboratory technician (5, 38, 39, 40). 
Culture and amplification techniques (PCR), which are compared 
in this study, are becoming widely used with high sensitivity and 
specificity.  Traditionally, diagnosis of trichomoniasis is based on 
clinical grounds. In women, the characteristic vaginal discharge, 
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including color and odor, are poor predictors of T. vaginalis (29, 31). 
Diagnosis based on symptoms is difficult, since symptoms are not 
sufficient to diagnose T. vaginalis infection reliably.  In addition the 
symptoms of trichomoniasis usually mimic those of other STDs 
making laboratory diagnosis a necessity (2, 36). 
The best promising alternative to diagnose T.vaginalis will be 
molecular techniques .Recently, a number of PCR assays (42,43) 
have been developed for the detection of T. vaginalis and these assays 
have generally proved more sensitive than culture; however, PCR 
also requires a dedicated laboratory, sophisticated equipment, and 
specially trained laboratorians (5). Molecular diagnostic techniques 
enjoy high sensitivity and specificity when compared to conventional 
methods (41, 42). 
In this study, a total of 1207 women of childbearing age were 
screened for trichomoniasis.  Vaginal swabs were cultured and 
interpreted as described before.  Culture is considered to be the 
reference method or the “gold standard” for diagnosing T. vaginalis. 
  In this study, 164 out of 1207 (13.6%) women screened for 
trichomoniasis were found to be infected with T. vaginalis by culture. 
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High infection rate was observed in Hebron (18.9 %) and Salfit 
(20 %), these two districts are located near major Israeli settlements 
in the West Bank. Palestinian men from these latter two districts 
working in Israeli territories may be the source of high infection rate. 
Married women showed an infection rate of (13.6%). The 
infection rate of T. vaginalis was found to be the higher (20.7%) 
among young women of reproductive age (15 to 18 years old). 
Similar results were reported by various studies, in NewYork 13-25% 
of women where attending gynecology clinics were diagnosed for 
trichomoniasis (49), in Missouri, USA 15% of sexually active 
adolescents (50) and 12.9% in adolescent girls (51). A study done on 
women visiting STDs clinics in central North Carolina using PCR-
based enzyme linked immunosorbent assay, the infection rate among 
these women was found to be 16.7% (52). 
Another study on adolescent girls in Birmingham, Alabama, 
reported an infection rate of 12.9% (53).  The reported results from 
these studies are similar to the results obtained by us. Another study 
on women visiting STDs clinics reported a higher infection rate of 
40% (37). It is clear from the previous information that the infection 
rate of T. vaginalis depends on the patient population studied and the 
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diagnostic method used. Prostitutes have the highest infection rate of 
50-70% (49). 
It is apparent that disease occurrence correlates with the level of 
sexual activity of the group of women being studied. Sexually active 
women are at an increased risk for vaginitis because the presence of 
semen in the vagina may raise the pH and thereby allow for a 
proliferation of pathogenic anaerobic bacteria (17). However, the 
infection may also be acquired from toilet facilities, medical 
instruments or the exchange of underclothing. Other factors such as 
the susceptibility of the host, her physiological condition, the 
virulence and size of the inoculums, as well as social habits and 
hygiene conditions, might have an effect on the pathogenesis of these 
organisms (4, 6). 
The infection rate of these pathogens was higher among camp 
residents for T. vaginalis (25.4%) than residents of rural and urban 
area (12.6-14.3%) (Table 2). This may be due to the lack of hygiene 
and crowded area of the camp. 
Pregnant women showed an infection rate of 28.1%.  A study on 
pregnant women done on inmates in New York City had reported a 
rate of infection of 47% (54). The reason for the high rate of 
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trichomoniasis in pregnant women can be attributed to the increased 
pelvic vascularity and elevated estrogen levels. Estrogen increases the 
rate of growth and maturation of the vaginal squamous epithelial cells 
(55). Estrogen can also increase the acidity (lower pH) of the vagina; 
the mechanism for lower pH is attributed to a general increase in 
metabolic activity under the influence of estrogen. The glycogen in 
the vaginal epithelium breaks down and results in increased lactic 
acid. The lower pH (3.5-6) is thought to ward off infection to some 
degree and alter the growth of pathogenic bacteria in the vagina (30).  
Data obtained in this study support the role of contraceptives in 
reducing the rate of infection by T. vaginalis.  It was found that 
women, who did not use contraceptives, had an infection rate of 
17.1%.  The infection rate among women using oral contraceptives 
was found to be 9.2%. This significant decrease in the rate of 
trichomoniasis may be due to the progestin component causing 
thickening of the cervical mucosa, which inhibits sperm and bacterial 
penetration (30, 56). The decreased duration of menstrual flow that 
accompanies the use of oral contraceptives theoretically also creates a 
shorter interval in which bacterial colonization may occur (30, 56). 
The infection rate when barrier contraceptives (condoms) were used 
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was 11.1%. Barrier contraceptives (condoms) has proven to be the 
most effective mechanical barrier to various microorganisms (56,57). 
Thus women using either barrier or oral contraceptives in the 6 
months before pregnancy are far less likely to be colonized by T. 
vaginalis (58). 
In this study, the infection rate of T. vaginalis in lactating women 
was found to be 11.4%. Although this result is somewhat lower than 
results obtained for married women (13.6%), it is significantly lower 
than the rate obtained for young women of reproductive age (20.7%).  
The infection rate of T. vaginalis among Iraqi lactating women 
was found to be 6.5% which is much lower than our results (29).  
Symptomatic vaginal trichomoniasis is extremely unusual in 
lactating patients, since the glycogen-poor atrophic vagina of the 
breastfeeding woman is relatively hostile to the trichomonad (30, 55). 
The infection rate of T. vaginalis among women of different 
socioeconomic status and different educational levels was found to be 
12.8% to 15.8%. These results are comparable to the results obtained 
for married women. These factors have no significant effect on the 
rate of trichomoniasis (57). Similar results were reported by study 
done in Basra, Iraq where no statistically significant differences in the 
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infection rate by T. vaginalis in relation to occupation, level of 
education or economic status was observed. 
Traditionally, diagnosis of T. vaginalis was based on clinical signs 
and symptoms. Such symptoms include vaginal discharge, irritation, 
genital soreness, pelvic pain, burning sensation and vaginal pH. It 
should be emphasized here that 10-50% of women may be 
asymptomatic (19, 11, 36, 48).  
The rate of infection with T. vaginalis in symptomatic women was 
comparable to that obtained for married women.  The infection rate as 
related to the various symptoms and ranged from 13.1% to 15.9%. 
These results do not correlate any particular symptom with increased 
rate of trichmoniasis. Earlier studies done by Reine et al., 1990, 
correlated the symptoms with the wet mount identification method of 
the organism (49). Considering the lack of accuracy and decreased 
sensitivity (< 40%), for this method, these results can be questionable. 
Other studies reported that a pH greater than 4.5 was found in 80 to 
90 % of patients with trichomoniasis (2, 10, 21). 
In this study, 164 specimens out of 1207 attending reproductive 
health clinics were found to be positive by culture method. A total of 
100 specimens were randomly selected for PCR analysis. The primer 
 43 
set BTUB 9/2 was used to amplify a 112-bp fragment. Only 82 
specimens (82%) of T. vaginalis were successfully detected by PCR 
giving the single predicted product of 112-bp in agarose gel 
electrophoresis. 
Culture is considered to be the gold standard; with modified 
Diamond’s medium has high sensitivity of 92-95% and specificity 
near 100% (37). The disadvantage of the culture method is the cost, 
the time delay for a diagnosis (usually 2-7 days), and the need to 
delay treatment until the results are available. Patients will continue 
to be infectious to others during this time. In addition, trichomoniasis 
culture medium is not available to many physicians. Many studies 
were conducted to compare the diagnostic sensitivity of PCR and 
culture. One study was done on 337 women (59). PCR had the 
highest sensitivity for T. vaginalis, detecting 84% of samples as 
compared to 78% by culture method. Another study was conducted in 
Belgium to compare culture and different PCR methods (60). In the 
later study, there were variations in the different PCR assays 
depending on the primer set used. The prevalence was found to be 
7.7% with culture as compared to 18.8% with PCR and gel 
electrophoresis. 
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It is apparent that PCR methods have high sensitivity and 
specificity with several advantages over other diagnostic techniques.  
PCR results can be available in 2 to 3 days with high sensitivity and it 
is cost effective when compared to the cost of culture. 
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4.1 Conclusion and Recommendation 
1. In conclusion, this is the first study to be conducted on one of the 
most probably common sexually transmitted diseases in Palestine, 
trichomoniasis. The infection rate was found to be 13.6% which is 
mainly obtained from examining normal women attending 
reproductive health clinics. 
2.  Sexually transmitted diseases should be of public health concern 
in Palestine, therefore immediate intervention and rapid action by 
the Ministry of Health like surveillance for STDs is required in 
order to prevent and control such diseases. 
3. Regarding prevention and treatment, both partners should receive 
careful examination and treatment once infection is suspected in 
either one of them.  
4. Sterile medical examination instruments must   be used at the 
clinic to prevent transmission of the disease. 
5.  Routine screening and providing suitable treatment for women 
with trichomoniasis before any reproductive tract surgery as well 
as before pregnancy should be done.  
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6. In case of infection of either the woman or her partner, barrier 
protection (condoms) should be used during intercourse until the 
infection is eradicated in both partners.  
7. The population must be educated about this disease and the means 
of its transmission, since education on sexual behavior and genital 
hygiene may help in its prevention and control. 
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6. Annexes 
6.1 Annex (1) 
 
Distribution of the sample in the different districts of West Bank 
(according to the last national population count on 2003) 
 
District Estimated population 2003 Sample size 
Hebron 505694 295 
Bethlehem 169317 110 
Jerusalem 144835 59 
Ramallah 269827 158 
Jericho 43545 40 
Nablus 318240 186 
Jenin 289841 169 
Tulkarem 163397 95 
Salfit 60130 35 
Qalqilia 90729 53 
Total west Bank 2055555 1200 
 
 
 
 
 
 
 
 54 
6.2 Annex (2) 
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